United Therapeutics Corporation (Nasdaq: UTHR ) today announced positive results from its phase 1 study of miroliver ELAP®, an external liver assist product, in patients with acute forms of liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results